MedTrace Logo

Different Oral Iron Dosing Regimens in Treatment of Iron Deficency Anemia in Patients With Chronic Kidney Disease

NCT06521216 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2024-07-25

No results posted yet for this study

Summary

Comparing between the efficacy of alternate day oral iron dose, once daily and thrice daily dose in improving anemia in CKD patients

Conditions

Interventions

DRUG

Ferrous sulfate

all patients will receive 200 mg elemental iron (ferrous sulphate)

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Farrag S Mohamed · Assiut University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-08-01
Primary Completion
2025-08-01
Completion
2025-08-01

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06521216 on ClinicalTrials.gov